Filter News
Area of Research
- (-) Neutron Science (5)
- Biological Systems (1)
- Biology and Environment (4)
- Clean Energy (2)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (2)
- Fusion and Fission (1)
- Fusion Energy (1)
- Isotopes (2)
- Materials (6)
- Materials for Computing (1)
- National Security (1)
- Nuclear Science and Technology (3)
- Quantum information Science (3)
- Supercomputing (10)
News Topics
- (-) Biomedical (3)
- (-) Quantum Science (2)
- 3-D Printing/Advanced Manufacturing (2)
- Artificial Intelligence (2)
- Bioenergy (2)
- Biology (2)
- Chemical Sciences (1)
- Clean Water (1)
- Composites (1)
- Computer Science (6)
- Coronavirus (2)
- Energy Storage (2)
- Environment (3)
- Fusion (1)
- High-Performance Computing (1)
- Machine Learning (1)
- Materials (2)
- Materials Science (6)
- Microscopy (1)
- Nanotechnology (2)
- Neutron Science (22)
- Nuclear Energy (1)
- Physics (3)
- Quantum Computing (1)
- Transportation (1)
Media Contacts
A team led by the U.S. Department of Energy’s Oak Ridge National Laboratory demonstrated the viability of a “quantum entanglement witness” capable of proving the presence of entanglement between magnetic particles, or spins, in a quantum material.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Using complementary computing calculations and neutron scattering techniques, researchers from the Department of Energy’s Oak Ridge and Lawrence Berkeley national laboratories and the University of California, Berkeley, discovered the existence of an elusive type of spin dynamics in a quantum mechanical system.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.